NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Collections About News Help Login

Due to the lapse in federal government funding, NASA is not updating this website. We sincerely regret this inconvenience.

Back to Results
Effect of the enzymatic inhibitor of Kunitz on the gastric lesions from reserpine, from phenylbutazone, from pyloric ligation and by restraint in the ratThe protective effects of certain polypeptides on gastric ulcerations caused from reserpine and phenylbutazone in the rate were studied. It was found that the Kunitz enzymatic inhibitor exerts a protective action in regard to gastric lesions. However, the inhibitor did not change the development of Shay ulcers and stress ulcers from restraint.
Document ID
19800010405
Acquisition Source
Legacy CDMS
Document Type
Reprint (Version printed in journal)
Authors
Guerrin, F. (NASA Headquarters Washington, DC United States)
Demaille, A. (NASA Headquarters Washington, DC United States)
Merveille, P. (NASA Headquarters Washington, DC United States)
Bel, C. (NASA Headquarters Washington, DC United States)
Date Acquired
September 4, 2013
Publication Date
February 1, 1980
Subject Category
Life Sciences (General)
Report/Patent Number
NASA-TM-76027
Report Number: NASA-TM-76027
Accession Number
80N18681
Funding Number(s)
CONTRACT_GRANT: NASW-3198
Distribution Limits
Public
Copyright
Work of the US Gov. Public Use Permitted.

Related Records

There are no records associated with this record.
No Preview Available